The Democratic governors of Washington, Oregon and California announced Wednesday that they created an alliance to safeguard health policies, believing the Trump administration is putting Americans’ health and safety at risk by politicizing the U.S. Centers for Disease Control and Prevention.

The move comes with COVID-19 cases rising and as Health Secretary Robert F. Kennedy Jr. has restructured and downsized the CDC and attempted to advance anti-vaccine policies that are contradicted by decades of scientific research. Concerns about staffing and budget cuts were heightened after the White House sought to oust the agency’s director and some top CDC leaders resigned in protest.

“The CDC has become a political tool that increasingly peddles ideology instead of science, ideology that will lead to severe health consequences,” the governors said in a joint statement.

“The dismantling of public health and dismissal of experienced and respected health leaders and advisers, along with the lack of using science, data, and evidence to improve our nation’s health are placing lives at risk,” California State Health Officer Erica Pan said in the news release.

Washington state Health Secretary Dennis Worsham said public health is about prevention — “preventing illness, preventing the spread of disease, and preventing early, avoidable deaths.”

“Vaccines are among the most powerful tools in modern medicine; they have indisputably saved millions of lives,” Oregon Health Director Sejal Hathi said. “But when guidance about their use becomes inconsistent or politicized, it undermines public trust at precisely the moment we need it most.”

Partnership seeks expert medical advice

The partnership plans to coordinate health guidelines by aligning immunization plans based on recommendations from respected national medical organizations, said a joint statement from Gov. Bob Ferguson of Washington, Gov. Tina Kotek of Oregon and Gov. Gavin Newsom of California.

U.S. Department of Health and Human Services spokesman Andrew G. Nixon shot back in a statement Wednesday that “Democrat-run states that pushed unscientific school lockdowns, toddler mask mandates, and draconian vaccine passports during the COVID era completely eroded the American people’s trust in public health agencies.”

He said the administration’s Advisory Committee on Immunization Practices “remains the scientific body guiding immunization recommendations in this country, and HHS will ensure policy is based on rigorous evidence and Gold Standard Science, not the failed politics of the pandemic.”

Florida announced Wednesday that it plans to phase out all childhood vaccine mandates as Republican Gov. Ron DeSantis plans to curb vaccine requirements and other health mandates during the COVID-19 pandemic.

Meanwhile, public health agencies across the country have started taking steps to ensure their states have access to vaccines after U.S. regulators came out with new policies that limited access to COVID-19 shots.

Illinois Gov. JB Pritzker’s health department said last week it is seeking advice from medical experts and its own Immunization Advisory Committee on COVID-19 vaccines and other immunizations for the fall respiratory season.

The health department plans to provide citizens “with specific guidance by the end of September to help Illinois health care providers and residents make informed decisions about vaccination and protecting themselves and their loved ones,” Health Director Sameer Vohra said in a statement.

A woman branded as the “Ketamine Queen” pleaded guilty Wednesday to selling Matthew Perry the drug that killed him, becoming the fifth and final defendant charged in Perry’s overdose death to admit guilt.

Jasveen Sangha pleaded guilty to five federal charges, including providing the ketamine that led to Perry’s death. Her trial had been planned to start later this month.

Perry’s mother, Suzanne Perry, and his stepfather, “Dateline” reporter Keith Morrison, sat in the audience. It was their first time attending court proceedings since the announcement of the indictments one year ago.

Wearing tan jail garb, Sangha stood in court Wednesday next to her attorney Mark Geragos as she repeated “guilty” five times when U.S. District Court Judge Sherilyn Peace Garnett asked for her pleas.

Before that, she answered “yes, your honor” to dozens of procedural questions, hedging slightly when the judge asked if she knew the drugs she was giving to co-defendant and middleman Erik Fleming were going to Perry.

“There was no way I could tell 100%,” she said. She later added, to a similar question on vials of ketamine she gave to Fleming, that “I didn’t know if all of them or some of them” were bound for Perry. The comments didn’t affect her plea agreement.

Prosecutors had cast Sangha, a 42-year-old citizen of the U.S. and the U.K., as a prolific drug dealer who was known to her customers as the “Ketamine Queen,” using the term often in press releases and court documents.

Making good on a deal she signed on Aug. 18, Sangha pleaded guilty to one count of maintaining a drug-involved premises, three counts of distribution of ketamine, and one count of distribution of ketamine resulting in death.

“She feels horrible about all of this. Nobody wants to be in the chain of causation for lack of a better term,” Geragos said outside the federal courthouse in downtown Los Angeles. “She feels horrible and she’s felt horrible since day one.”

Sangha admitted to selling drugs directly to 33-year-old Cody McLaury, who died from an overdose in 2019. McLaury had no connection to Perry.

Prosecutors agreed to drop three other counts.

Geragos, whose other clients have included Michael Jackson, Chris Brown and the Menendez brothers, told the judge that the deal was reached “after a robust back-and-forth with the government.”

The final plea deal came a year after federal prosecutors announced the indictments in Perry’s Oct. 28, 2023 death after a sweeping investigation.

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.

Health insurance will grow more expensive in many corners of the market in 2026, and coverage may shrink. That could leave patients paying more for doctor visits and dealing with prescription coverage changes.

Price increases could be especially stark in individual coverage marketplaces, where insurers also are predicting the federal government will end some support that helps people buy coverage.

“We’re in a period of uncertainty in every health insurance market right now, which is something we haven’t seen in a very long time,” said Larry Levitt, an executive vice president at the nonprofit KFF, which studies health care.

What’s hitting insurers

In conference calls to discuss recent earnings reports, insurers ticked off a list of rising costs: More people are receiving care. Visits to expensive emergency rooms are rising, as are claims for mental health treatments.

Insurers also say more healthy customers are dropping coverage in the individual market. That leaves a higher concentration of sicker patients who generate claims.

Enrollment in the Affordable Care Act’s insurance marketplaces swelled the past few years. But a crackdown on fraud and a tightening of eligibility verifications that were loosened during the COVID-19 pandemic makes it harder for some to stay covered, Jefferies analyst David Windley noted.

People who use little care “are disappearing,” he said.

Prescription drugs pose another challenge, especially popular and expensive diabetes and obesity treatments sometimes called GLP-1 drugs. Those include Ozempic, Mounjaro, Wegovy and Zepbound.

“Pharmacy just gives me a headache, no pun intended,” said Vinnie Daboul, Boston-based managing director of the employee benefits consultant RT Consulting.

There are more super expensive drugs

New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers say. Those drugs, which target rare diseases, and some newer cancer treatments are part of the reason Sun Life Financial covered 47 claims last year that cost over $3 million.

The financial services company covers high-cost claims for employers that pay their own medical bills. Sun Life probably had no claims that expensive a decade ago and maybe “a handful at best” five years ago, said Jen Collier, president of health and risk solutions.

Some of these drugs are rarely used, but they cause overall costs to rise. That raises insurance premiums.

“It’s adding to medical (cost growth) in a way that we haven’t seen in the past,” Collier said.

Marketplace pain is in the forecast

Price hikes will be most apparent on the Affordable Care Act’s individual coverage marketplaces. Insurers there are raising premiums around 20% in 2026, according to KFF, which has been analyzing state regulatory filings.

But the actual hike consumers see may be much bigger. Enhanced tax credits that help people buy coverage could expire at the end of the year, unless Congress renews them.

If those go away, customer coverage costs could soar 75% or more, according to KFF.

Business owner Shirley Modlin worries about marketplace price hikes. She can’t afford to provide coverage for the roughly 20 employees at 3D Design and Manufacturing in Powhatan, Virginia, so she reimburses them $350 a month for coverage they buy.

Modlin knows her reimbursement only covers a slice of what her workers pay. She worries another price hike might push some to look for work at a bigger company that offers benefits.

“My employee may not want to go to work for a large corporation, but when they consider how they have to pay their bills, sometimes they have to make sacrifices,” she said.
Employers may shift costs

Costs also have been growing in the bigger market for employer-sponsored coverage, the benefits consultant Mercer says. Employees may not feel that as much because companies generally pay most of the premium.

But they may notice coverage changes.

About half the large employers Mercer surveyed earlier this year said they are likely or very likely to shift more costs to their employees. That may mean higher deductibles or that people have to pay more before they reach the out-of-pocket maximum on their coverage.

Drug coverage changes are possible

For prescriptions, patients may see caps on those expensive obesity treatments or limits on who can take them.

Some plans also may start using separate deductibles for their pharmaceutical and medical benefits or having patients pay more for their prescriptions, Daboul said.

Coverage changes could vary around the country, noted Emily Bremer, president of a St. Louis-based independent insurance agency, The Bremer Group.

Employers aren’t eager to cut benefits, she said, so people may not see dramatic prescription coverage changes next year. But that may not last.

“If something doesn’t give with pharmacy costs, it’s going to be coming sooner than we’d like to think,” Bremer said.

A federal website that informs the public about what information agencies are collecting and allows for public comment went down last weekend, and it has only been partially restored. The outage has raised concerns among advocates who already were troubled by the disappearance of data sets from government websites after President Donald Trump began his second term.

The https://www.reginfo.gov/public/ website went offline at the end of last week and was partially restored this week. Data was missing after Aug. 1, according to dataindex,us, a collective of data scientists and advocates who monitor changes in federal data sets.

As of Thursday, the website’s landing page said, it was “currently undergoing revisions.” Emailed inquiries to the Office of Management and Budget and General Services Administration weren’t returned on Thursday.

In February, the Centers for Disease Control and Prevention’s official public portal for health data, data.cdc.gov, was taken down entirely but subsequently went back up. Around the same time, when a query was made to access certain public data from the U.S. Census Bureau’s most comprehensive survey of American life, users for several days got a response that said the area was “unavailable due to maintenance” before access was restored.

Researchers Janet Freilich and Aaron Kesselheim examined 232 federal public health data sets that had been modified in the first quarter of this year and found that almost half had been “substantially altered,” with the majority having the word “gender” switched to “sex,” they wrote last month in The Lancet medical journal.

Former Census Bureau official Chris Dick, who is part of the dataindex.us team, said Thursday that no one is quite sure what is going on with the regulatory affairs website, whether there was an update with technical difficulties because of staffing shortages from job cuts or something more nefarious.

“This is key infrastructure that needs to come back,” Dick said. “Usually, you can fix this quickly. It’s not super normal for this to go on for days.”

The first domino in a growing national redistricting battle is likely to fall Wednesday as the Republican-controlled Texas legislature is expected to pass a new congressional map creating five new winnable seats for the GOP.

The vote follows prodding by President Donald Trump, eager to stave off a midterm defeat that would deprive his party of control of the House of Representatives, and weeks of delays after dozens of Texas Democratic state lawmakers fled the state in protest. Some Democrats returned Monday, only to be assigned round-the-clock police escorts to ensure their attendance at Wednesday’s session. Those who refused to be monitored were confined to the House floor, where they protested on a livestream Tuesday night.

Furious national Democrats have vowed payback for the Texas map, with California’s legislature poised to approve new maps adding more Democratic-friendly seats later this week. The map would still need to be approved by that state’s voters in November.

Normally, states redraw maps once a decade with new census figures. But Trump is lobbying other conservative-controlled states like Indiana and Missouri to also try to squeeze new GOP-friendly seats out of their maps as his party prepares for a difficult midterm election next year.

In Texas, Democrats spent the day before the vote continuing to draw attention to the extraordinary lengths the Republicans who run the legislature were going to ensure it takes place. Democratic state Rep. Nicole Collier started it when she refused to sign what Democrats called the “permission slip” needed to leave the House chamber, a half-page form allowing Department of Public Safety troopers to follow them. She spent Monday night and Tuesday on the House floor, where she set up a livestream while her Democratic colleagues outside had plainclothes officers following them to their offices and homes.

Dallas-area Rep. Linda Garcia said she drove three hours home from Austin with an officer following her. When she went grocery shopping, he went down every aisle with her, pretending to shop, she said. As she spoke to The Associated Press by phone, two unmarked cars with officers inside were parked outside her home.

“It’s a weird feeling,” she said. “The only way to explain the entire process is: It’s like I’m in a movie.”

The trooper assignments, ordered by Republican House Speaker Dustin Burrows, was another escalation of a redistricting battle that has widened across the country. Trump is pushing GOP state officials to tilt the map for the 2026 midterms more in his favor to preserve the GOP’s slim House majority, and Democrats nationally have rallied around efforts to retaliate.

House Minority Leader Gene Wu, from Houston, and state Rep. Vince Perez, of El Paso, stayed overnight with Collier, who represents a minority-majority district in Fort Worth.

On Tuesday, more Democrats returned to the Capitol to tear up the slips they had signed and stay on the House floor, which has a lounge and restrooms for members.

Dallas-area Rep. Cassandra Garcia Hernandez called their protest a “slumber party for democracy,” and she said Democrats were holding strategy sessions on the floor.

“We are not criminals,” Houston Rep. Penny Morales Shaw said.

Collier said having officers shadow her was an attack on her dignity and an attempt to control her movements.

Burrows brushed off Collier’s protest, saying he was focused on important issues, such as providing property tax relief and responding to last month’s deadly floods. His statement Tuesday morning did not mention redistricting, and his office did not immediately respond to other Democrats joining Collier.

“Rep. Collier’s choice to stay and not sign the permission slip is well within her rights under the House Rules,” Burrows said.

Under those rules, until Wednesday’s scheduled vote, the chamber’s doors are locked, and no member can leave “without the written permission of the speaker.”

To do business Wednesday, 100 of 150 House members must be present. The GOP plan is designed to send five additional Republicans from Texas to the U.S. House. Texas Democrats returned to Austin after Democrats in California launched an effort to redraw their state’s districts to take five seats from Republicans.

Democrats also said they were returning because they expect to challenge the new maps in court.